Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ranjeet Prasad Dash, Rana Rais & Nuggehally R. Srinivas. (2018) Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion. Xenobiotica 48:9, pages 945-957.
Read now
Read now
Samaneh Soleymani, Roodabeh Bahramsoltani, Roja Rahimi & Mohammad Abdollahi. (2017) Clinical risks of St John’s Wort (Hypericum perforatum) co-administration. Expert Opinion on Drug Metabolism & Toxicology 13:10, pages 1047-1062.
Read now
Read now
Janne Hukkanen. (2012) Induction of cytochrome P450 enzymes: a view on human in vivo findings. Expert Review of Clinical Pharmacology 5:5, pages 569-585.
Read now
Read now
Roja Rahimi & Mohammad Abdollahi. (2012) An update on the ability of St. John's wort to affect the metabolism of other drugs. Expert Opinion on Drug Metabolism & Toxicology 8:6, pages 691-708.
Read now
Read now
Articles from other publishers (19)
Wenhao Cheng, Kexin Xia, Siyang Wu & Yingfei Li. (2023) Herb-Drug Interactions and Their Impact on Pharmacokinetics: An Update. Current Drug Metabolism 24:1, pages 28-69.
Crossref
Crossref
Veronica Di Paolo, Francesco Maria Ferrari, Italo Poggesi & Luigi Quintieri. (2022) Quantitative Prediction of Drug Interactions Caused by Cytochrome P450 2B6 Inhibition or Induction. Clinical Pharmacokinetics 61:9, pages 1297-1306.
Crossref
Crossref
Gita Kholghi, Shirin Arjmandi-Rad, Mohammad-Reza Zarrindast & Salar Vaseghi. (2022) St. Johnʼs wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?. Naunyn-Schmiedeberg's Archives of Pharmacology 395:6, pages 629-642.
Crossref
Crossref
Tomoko Hama, Michihiko Koeda, Yumiko Ikeda, Amane Tateno, Tokuhiro Kawara, Hidenori Suzuki & Yoshiro Okubo. (2021) Bupropion increases cerebral activation in auditory affective processing: A randomized controlled fMRI study. Neuroscience Letters 749, pages 135716.
Crossref
Crossref
Fatima Zahra Marok, Laura Maria Fuhr, Nina Hanke, Dominik Selzer & Thorsten Lehr. (2021) Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network. Pharmaceutics 13:3, pages 331.
Crossref
Crossref
J.K. Roydhouse, L.A. Menapace, H. Xia, P. Song, T. Berman, R. Agarwal, D.L. Suzman, K. Wright, J.A. Beaver & P.G. Kluetz. (2020) Concomitant botanical medicine use among patients participating in commercial prostate cancer trials. Complementary Therapies in Medicine 54, pages 102549.
Crossref
Crossref
Jukka Hakkola, Janne Hukkanen, Miia Turpeinen & Olavi Pelkonen. (2020) Inhibition and induction of CYP enzymes in humans: an update. Archives of Toxicology 94:11, pages 3671-3722.
Crossref
Crossref
Kuppusamy Asokkumar & Subramaniam Ramachandran. 2020. Herbal Medicine in India. Herbal Medicine in India
547
571
.
Fan Zhang, Yan Li, Jingqiu Hu, Jinhua Zhong & Huafang Li. (2018) Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics 44:3, pages 339-352.
Crossref
Crossref
Sigrun Chrubasik-Hausmann, Julia Vlachojannis & Andrew J McLachlan. (2019)
Understanding drug interactions with St John's wort (
Hypericum perforatum
L.): impact of hyperforin content
. Journal of Pharmacy and Pharmacology 71:1, pages 129-138.
Crossref
Crossref
Lilian W. Kibathi, SoHyun Bae, Scott R. Penzak & Parag Kumar. (2018) Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood–Cerebrospinal Fluid Barrier and Blood–Brain Barrier. European Journal of Drug Metabolism and Pharmacokinetics 43:6, pages 619-635.
Crossref
Crossref
. (2017) Be aware that the use of tobacco, cannabinoids and smoking cessation may result in pharmacokinetic interactions with other drugs. Drugs & Therapy Perspectives 33:7, pages 339-344.
Crossref
Crossref
Gail D. Anderson & Lingtak-Neander Chan. (2016) Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. Clinical Pharmacokinetics 55:11, pages 1353-1368.
Crossref
Crossref
Lei Wang, ChienWei Chiang, Hong Liang, Hengyi Wu, Weixing Feng, Sara K. Quinney, Jin Li & Lang Li. (2015) How to Choose In Vitro Systems to Predict In Vivo Drug Clearance: A System Pharmacology Perspective. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Hong-Guang Xie & Ying-Dong Zhang. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
469
506
.
Shaojun Shi & Ulrich Klotz. (2012) Drug Interactions with Herbal Medicines. Clinical Pharmacokinetics 51:2, pages 77-104.
Crossref
Crossref
Alexander V. LyubimovMartin S. Lennard. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
27
.
Angelo A. Izzo. (2012) Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data. Medical Principles and Practice 21:5, pages 404-428.
Crossref
Crossref
Hong-Guang Xie, Jian-Jun Zou, Zuo-Ying Hu, Jun-Jie Zhang, Fei Ye & Shao-Liang Chen. (2011) Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyond. Pharmacology & Therapeutics 129:3, pages 267-289.
Crossref
Crossref